Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Auxellence announces results of AG&SM and Update on Plan of Arrangement.

C.TMED

(via Thenewswire.ca)

VANCOUVER, BC, / TNW-ACCESSWIRE / Monday, June 16, 2014 - Auxellence Health Corporation (CSE:AID) (the "Company" or "Auxellence") today announces that at the Annual General and Special Meeting all resolutions were approved. In addition, Mr. J. Scott Munro, was nominated as a director but will not join the Auxellence board of directors until a previously disclosed transaction is completed, cancelled or developed enough for any potential conflicts that are needed to be addressed, can be done so while at an arms length basis. The company is also pleased to announce that subsequent to the meeting it has received the Final Order from the Supreme Court of BC for the Plan of Arrangement.

Contact:

Sydney Au, President & CEO

Auxellence Health Corporation

Email: sydau945@gmail.com

Phone: (604) 780-3311

About Auxellence Health Corporation

Auxellence is a health technology company that aims to provide high-level online health services for resolving common health problems. The company offers an extensive platform for physiologically interactive computing supporting therapeutic-diagnostic (theranostic) devices, expert systems, and recommender applications for personal health management. The initial focus is on weight management and skin conditions. The platform involves a unique body-machine feedback interactivity that allows the system to continually customize its operation and recommendations, according to the consumer's immediate health needs and goals.

Disclaimer for Forward-Looking Information Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. Except as required by law, the Company does not intend to update any changes to such statements. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Copyright (c) 2014 TheNewswire - All rights reserved.